RxStrategies Inc.
Skip Devanny serves as the Chief Executive Officer, Chief Operating Officer, Chief Revenue Officer, and a member of the Board of Directors at RxStrategies Inc. since October 2015. Additionally, Skip holds a position on the Board of Directors for Community Voices for 340B since April 2021. Prior experience includes serving as Vice President of Sales at Talyst from May 2008 to October 2015, and as Director of 340b Solutions at Cerner Corporation from May 2001 to September 2008. Skip's educational background includes a Master of Business Administration from Washington University in St. Louis and a Bachelor of Science in Business Administration from Trinity University. Skip is a graduate of Pembroke Hill School.
This person is not in any teams
This person is not in any offices
RxStrategies Inc.
RxStrategies offers a proprietary, comprehensive turnkey solution that allows Community Health Centers (CHCs) to gain access to significantly discounted prices on prescription drugs under Section 340B of the Public Health Service Act. Collectively, these CHCs serve 12 million patients, many of which are lower income or uninsured, and write anestimated 215 million prescriptions annually. RxStrategies is pleased to join with the National Association of Community Health Centers (NACHC) in providing the Access RxS program, which allows these CHCs and their patients to realize substantial savings on prescription drugs.